China New Healthcare Investment Initiatives – 1) Allows Full Foreign-Owned Hospitals in 8 Major Cities & an Island – Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou, Shenzhen and Southern Island Province of Hainan, But Not Allowed to Buy Public Hospitals or Operate Businesses Relating to Chinese Medicine, 2) Biotechnology Sector to Open Up in Beijing, Shanghai, Southern Provinces of Guangdong & Hainan, 3) Foreign-Funded Firms Can Research, Provide Treatment & Production on Human Stem Cell & Gene Diagnosis Technology
13th September 2024 | Hong Kong
China new healthcare investment initiatives – 1) Allows full foreign-owned hospitals in 8 major cities & an island – Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou, Shenzhen and Southern Island Province of Hainan, but are not allowed to buy public hospitals or operate businesses relating to Chinese medicine. 2) The Biotechnology sector will open up in Beijing, Shanghai, and Southern Provinces of Guangdong & Hainan. 3) Foreign-funded firms can research, provide treatment & production on Human Stem Cell & Gene Diagnosis Technology.
“ China New Healthcare Investment Initiatives – 1) Allows Full Foreign-Owned Hospitals in 8 Major Cities & an Island – Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou, Shenzhen and Southern Island Province of Hainan, But Not Allowed to Buy Public Hospitals or Operate Businesses Relating to Chinese Medicine, 2) Biotechnology Sector to Open Up in Beijing, Shanghai, Southern Provinces of Guangdong & Hainan, 3) Foreign-Funded Firms Can Research, Provide Treatment & Production on Human Stem Cell & Gene Diagnosis Technology “
China New Healthcare Investment Initiatives – 1) Allows Full Foreign-Owned Hospitals in 8 Major Cities & an Island – Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou, Shenzhen and Southern Island Province of Hainan, But Not Allowed to Buy Public Hospitals or Operate Businesses Relating to Chinese Medicine, 2) Biotechnology Sector to Open Up in Beijing, Shanghai, Southern Provinces of Guangdong & Hainan, 3) Foreign-Funded Firms Can Research, Provide Treatment & Production on Human Stem Cell & Gene Diagnosis Technology
Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2024 Investment Day
- March 2024 - Hong Kong
- March 2024 - Singapore
- July 2024 - Hong Kong
- July 2024 - Singapore
- Sept 2024 - Hong Kong
- Sept 2024 - Singapore
- Oct 2024 - Hong Kong
- Nov 2024 - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit